Tuberculosis News and Research

Latest Tuberculosis News and Research

U.N. Secretary-General launches report aimed at meeting MDGs by 2015

U.N. Secretary-General Ban Ki-moon "warned on Tuesday that failure to meet" Millennium Development Goal (MDG) targets by the 2015 deadline could result in "increased instability, violence, epidemic diseases and overpopulation," Agence France-Presse/Mail & Guardian reports (3/17).

18 Mar 2010

Systemic underfunding of CDC's Division of Viral Hepatitis puts millions of Americans' health at risk

Warning that "systemic underfunding of the Centers for Disease Control's Division of Viral Hepatitis puts millions of Americans' health and well-being at risk," the National Viral Hepatitis Roundtable today called on the Administration to work with Congress to take decisive action this year to fix the funding failure for viral hepatitis screening, surveillance, and early intervention programs.

17 Mar 2010

Booster shot appears to improve TB resistance in previously vaccinated adults

A booster shot appears to improve tuberculosis (TB) resistance in previously vaccinated adults, according to new research in South Africa.

17 Mar 2010

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

Monash Institute of Pharmaceutical Science researchers, in collaboration with the biotechnology company Starpharma Holdings Ltd have developed a new method to deliver medications that may benefit thousands of patients with particular types of cancer, HIV and lymphatic conditions world-wide.

15 Mar 2010

Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing

Former President Bill Clinton and Bill Gates, co-chair of the Bill & Melinda Gates Foundation, said Wednesday at a Senate Foreign Relations Committee hearing "that U.S. investments in fighting [HIV/]AIDS, malaria and other diseases in underdeveloped nations save lives and play a vital role in improving America's image abroad," the Associated Press reports.

12 Mar 2010

Congress works on tariff-lowering legislation for Haiti as Preval meets with U.S. leaders in Washington

The Senate Finance Committee's chair, Max Baucus (D-Mont.), and top Republican, Charles Grassley (Iowa), are working with colleagues in the House on legislation that would lower tariffs in an effort to help Haiti's apparel industry and help the country recover from the major January earthquake, CQ Politics reports.

11 Mar 2010

British government, HIV/AIDS advocates warn decreased aid budgets could lead to reversals in HIV/AIDS treatment progress

Recent gains in the global fight against HIV/AIDS could be reversed as the "global economic downturn pinches poor countries' budgets and donors show signs of backing away from their promise to provide universal access to AIDS treatment," the British government together with Medecins Sans Frontieres warned Tuesday, Reuters AlertNet reports.

11 Mar 2010

Cempra Pharmaceuticals completes Phase 1 clinical trials of CEM-101 macrolide

Cempra Pharmaceuticals today announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announced plans to submit an IND to the FDA to begin a Phase 1 study with the company's intravenous formulation of CEM-101 in mid-2010.

10 Mar 2010

Strong, local leadership is the key for success of health departments and activities

The surge of funds for bioterrorism preparedness over the past decade does not appear to be improving local public health resources in general, according to research from Purdue University.

10 Mar 2010

UNAIDS director cautions against funding cuts to Global Fund

During an appeal to government and private donors to pledge money to the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday, UNAIDS Executive Director Michel Sidibe warned of the repercussions tightening budgets could play in the global fight against HIV/AIDS, the Associated Press reports.

10 Mar 2010

Opinions: Don't slow fight against HIV, TB, malaria; U.S. focus on women, girls

In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."

10 Mar 2010

False positives in screening tests

In many jurisdictions, tests for human immunodeficiency virus (HIV) are required screening for pregnant women. Some even suggest screening the entire population for HIV. The rationale is to administer powerful antiretroviral drugs to healthy individuals to "prevent transmission."

10 Mar 2010

66% of Americans believe that the U.S. has obligation to help poor children around the world

Despite an inward focus on domestic issues like healthcare and forward-looking concerns over global warming, an overwhelming number of Americans (66%) believes that the United States has an obligation to help poor children around the world.

10 Mar 2010

Global Fund releases latest impact data, projections for improving global health in next decade

By 2015, mother-to-child HIV transmission will be virtually eliminated and deaths from malaria and tuberculosis will continue to decline if health investments for the diseases are maintained or scaled up, according to an annual results report published Monday by the Global Fund to Fight AIDS, Tuberculosis and Malaria, Agence France-Presse/Africasia.com reports (3/8).

9 Mar 2010

Free online training Webinars to prepare nurses for continued relief efforts in Haiti launched

While disaster response is a highly technical and sensitive effort, the most qualified of disaster professionals require additional education or real-life experience to ensure that help is delivered effectively, safely and efficiently. To assist nursing professionals volunteering their services in Haiti, Chamberlain College of Nursing in cooperation with the Johnson & Johnson Campaign for Nursing's Future, will provide free online training Webinars hosted on the Gannett Healthcare Group's newly launched Haiti Web page to prepare nurses physically, mentally and culturally for the continued relief efforts.

6 Mar 2010

Recent releases in Global Health

The WHO's March Bulletin is a special themed issue focusing on communicable diseases in Southeast Asia. The publication addresses tuberculosis, cholera, neglected tropical diseases and family planning in the region (March 2010).

6 Mar 2010

Ban, Clinton launch voluntary travel donation for global health

Former President Bill Clinton and U.N. Secretary-General Ban Ki-moon in New York on Thursday launched MASSIVEGOOD - an initiative that allows travelers to make a $2 donation "to fight deadly diseases whenever they buy a plane ticket, book a hotel room or rent a car," Bloomberg/BusinessWeek reports (Varner, 3/4).

6 Mar 2010

MASSIVEGOOD launched to enable travelers make contributions towards major global health causes

UN Secretary-General Ban Ki-moon and President Bill Clinton join today with international recording artists will.i.am and David Guetta, South African singer Yvonne Chaka Chaka, and director Spike Lee, to launch MASSIVEGOOD, an innovative fundraising movement that will enable travelers to make a "micro-contribution" towards major global health causes every time they buy a plane ticket, reserve a hotel room or rent a car.

5 Mar 2010

Gene involved in susceptibility and resistance to TB identified

University of Washington researchers have identified a gene involved in susceptibility and resistance to tuberculosis. This same gene, they have found, has a role in the severity of leprosy, which is caused by a related pathogen. The researchers also have learned why this gene is important for susceptibility.

5 Mar 2010

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

Data evaluating the efficacy and safety of STELARA™ (ustekinumab) and REMICADE® (infliximab) in patients with plaque psoriasis who had an inadequate response to Enbrel® (etanercept) will be presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) in Miami, Fla., from March 5-9, 2010.

5 Mar 2010

Tuberculosis News and Research

Latest Tuberculosis News and Research

U.N. Secretary-General launches report aimed at meeting MDGs by 2015

Systemic underfunding of CDC's Division of Viral Hepatitis puts millions of Americans' health at risk

Booster shot appears to improve TB resistance in previously vaccinated adults

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing

Congress works on tariff-lowering legislation for Haiti as Preval meets with U.S. leaders in Washington

British government, HIV/AIDS advocates warn decreased aid budgets could lead to reversals in HIV/AIDS treatment progress

Cempra Pharmaceuticals completes Phase 1 clinical trials of CEM-101 macrolide

Strong, local leadership is the key for success of health departments and activities

UNAIDS director cautions against funding cuts to Global Fund

Opinions: Don't slow fight against HIV, TB, malaria; U.S. focus on women, girls

False positives in screening tests

66% of Americans believe that the U.S. has obligation to help poor children around the world

Global Fund releases latest impact data, projections for improving global health in next decade

Free online training Webinars to prepare nurses for continued relief efforts in Haiti launched

Recent releases in Global Health

Ban, Clinton launch voluntary travel donation for global health

MASSIVEGOOD launched to enable travelers make contributions towards major global health causes

Gene involved in susceptibility and resistance to TB identified

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Tuberculosis News and Research

Latest Tuberculosis News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in